Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) Income from Continuing Operations (2018 - 2025)

TransMedics has reported Income from Continuing Operations over the past 8 years, most recently at 18581000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 18581000.0 for Q4 2025, up 167.08% from a year ago — trailing twelve months through Dec 2025 was 103464000.0 (up 190.92% YoY), and the annual figure for FY2025 was 1114000.0, down 96.87%.
  • Income from Continuing Operations for Q4 2025 was 18581000.0 at TransMedics, down from 24319000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for TMDX hit a ceiling of 34882000.0 in Q2 2025 and a floor of 25422000.0 in Q3 2023.
  • Median Income from Continuing Operations over the past 5 years was 681500.0 (2023), compared with a mean of 3797850.0.
  • Biggest five-year swings in Income from Continuing Operations: tumbled 242.34% in 2023 and later soared 1318.18% in 2024.
  • TransMedics' Income from Continuing Operations stood at 31653000.0 in 2021, then tumbled by 122.02% to 6971000.0 in 2022, then surged by 133.91% to 2364000.0 in 2023, then surged by 194.29% to 6957000.0 in 2024, then skyrocketed by 167.08% to 18581000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 18581000.0 (Q4 2025), 24319000.0 (Q3 2025), and 34882000.0 (Q2 2025) per Business Quant data.